Gürbüz, Y. Et Al. 2024. The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data. Infectious Diseases and Clinical Microbiology , vol.6, no.3 , 216-224.

Gürbüz, Y., Kocagül-çelikbaş, A., Öztoprak, N., AYGEN, B., Batırel, A., Habiloğlu, A. D., ... Aktuğ-Demir, N.(2024). The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data. Infectious Diseases and Clinical Microbiology , vol.6, no.3, 216-224.

Gürbüz, Yunus Et Al. "The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data," Infectious Diseases and Clinical Microbiology , vol.6, no.3, 216-224, 2024

Gürbüz, Yunus Et Al. "The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data." Infectious Diseases and Clinical Microbiology , vol.6, no.3, pp.216-224, 2024

Gürbüz, Y. Et Al. (2024) . "The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data." Infectious Diseases and Clinical Microbiology , vol.6, no.3, pp.216-224.

@article{article, author={Yunus Gürbüz Et Al. }, title={The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data}, journal={Infectious Diseases and Clinical Microbiology}, year=2024, pages={216-224} }